All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Does testosterone fix low libido and emotional numbness in women?

Marcella Hill

TikTok creator

5.5M viewsWatch on TikTok→

Quick answer

Marcella Hill describes classic symptoms of hypoactive sexual desire disorder (HSDD), including absent libido and emotional blunting, which resolved after her second round of BHRT. Her gynecologist's dismissal despite symptoms is consistent with documented gaps in female androgen testing, where no validated low-testosterone threshold for women currently exists per JCEM guidelines. Compounded BHRT products she references are not FDA-approved and carry variable dosing risks distinct from studied hormone therapy formulations.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @beingmarcellahill actually say?

Marcella Hill describes years of zero libido, emotional numbness, and a marriage she nearly ended, all before she says her second round of bioidentical hormone therapy (BHRT) flipped a switch. Her core claim: "people are getting divorced because they have a hormone imbalance." She also says her gynecologist told her hormones were "normal," but that BHRT eventually restored her desire and emotional connection to her husband. She's not selling anything directly in this clip. She's telling a personal story. That matters for how we evaluate it.

The narrative arc is compelling: suffering, misdiagnosis, near-divorce, then recovery. But a personal story, even a sincere one with 5.5 million views, is not clinical evidence. It's a hypothesis. Let's stress-test it.

Does the science back this up?

Partially, yes. Low testosterone in women is genuinely linked to reduced sexual desire, and that connection has real evidence behind it. The ISSWSH (International Society for the Study of Women's Sexual Health) published a position statement in 2019 confirming that testosterone therapy can improve hypoactive sexual desire disorder (HSDD) in postmenopausal women. But "can help some women" is doing a lot of work here.

Davis et al. (2019, The Lancet Diabetes and Endocrinology) conducted a systematic review of 36 randomized controlled trials and found testosterone therapy did improve sexual function in women, including desire, arousal, and satisfaction. That's meaningful. However, the same review flagged that long-term safety data is limited, particularly for cardiovascular outcomes and breast cancer risk. The emotional numbness Marcella describes, the feeling of not loving her husband, is harder to pin directly on hormones. Mood and attachment involve dopamine, oxytocin, and serotonin systems in ways that aren't fully explained by testosterone levels alone. The science is real but messier than the video implies.

What did they get wrong (or right)?

Let's give credit where it's due. Marcella is right that female sexual dysfunction is undertreated and underdiagnosed. She's right that "everything was normal" is often an inadequate clinical response. Standard hormone panels frequently miss nuance: they may not test free testosterone, they don't always account for symptoms in context, and reference ranges for women's testosterone are poorly standardized. Wierman et al. (2014, Journal of Clinical Endocrinology and Metabolism) explicitly noted that no validated cutoff for low testosterone in women exists. So her frustration with her gynecologist isn't unfounded.

What she gets wrong, or at least oversimplifies: the leap from "I felt numb" to "hormone imbalance caused my marriage problems" skips several alternative explanations. Depression, perimenopause-related sleep disruption, anxiety, and relationship dynamics all produce similar symptoms. Attributing everything to hormones and BHRT specifically, a category of compounded products with inconsistent dosing and limited FDA oversight, is a significant jump. The "bioidentical" label also carries marketing weight that outruns the evidence. Compounded BHRT is not equivalent to FDA-approved hormone therapy products, and that distinction matters clinically.

What should you actually know?

If you identify with Marcella's story, here is what the evidence actually supports. Low libido and emotional blunting in women have real, testable biological contributors, including estrogen and testosterone levels, thyroid function, and cortisol patterns. These are worth investigating with a clinician who goes beyond a basic panel and takes symptoms seriously.

But BHRT specifically, meaning compounded bioidentical hormones, exists in a regulatory gray zone. The FDA has not approved most compounded BHRT products, and their hormone concentrations can vary between batches. FDA-approved hormone therapies, including transdermal testosterone products studied in clinical trials, are a more standardized option worth discussing. And the claim that hormone imbalance explains near-divorce, while emotionally resonant for many people, is not something you can confirm without ruling out depression, sleep disorders, and relational factors first.

The practical steps: ask your provider to test free testosterone and total testosterone, not just estradiol. Request symptom-based evaluation, not just numbers. And if a provider dismisses you with "everything is normal" while you feel anything but, find one who will actually listen.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does testosterone fix low libido and emotional numbness in women?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Does testosterone fix low libido and emotional numbness in women? should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Marcella Hill describes classic symptoms of hypoactive sexual desire disorder (HSDD), including absent libido and emotional blunting, which resolved after her second round of BHRT.

FormBlends verdict

Marcella Hill describes classic symptoms of hypoactive sexual desire disorder (HSDD), including absent libido and emotional blunting, which resolved after her second round of BHRT. Her gynecologist's dismissal despite symptoms is consistent with documented gaps in female androgen testing, where no validated low-testosterone threshold for women currently exists per JCEM guidelines. Compounded BHRT products she references are not FDA-approved and carry variable dosing risks distinct from studied hormone therapy formulations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Marcella Hill describes classic symptoms of hypoactive sexual desire disorder (HSDD), including absent libido and emotional blunting, which resolved after her second round of BHRT. Her gynecologist's dismissal despite symptoms is consistent with documented gaps in female androgen testing, where no validated low-testosterone threshold for women currently exists per JCEM guidelines. Compounded BHRT products she references are not FDA-approved and carry variable dosing risks distinct from studied hormone therapy formulations.
  • A 2019 systematic review of 36 RCTs (Davis et al., The Lancet Diabetes and Endocrinology) found testosterone therapy improved sexual desire, arousal, and satisfaction in women, but long-term cardiovascular and cancer safety data remain limited.
  • No validated lower cutoff for testosterone in women exists, per Wierman et al. (2014, JCEM), meaning a 'normal' result on a standard panel does not rule out clinically meaningful androgen insufficiency.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2019 systematic review of 36 RCTs (Davis et al., The Lancet Diabetes and Endocrinology) found testosterone therapy improved sexual desire, arousal, and satisfaction in women, but long-term cardiovascular and cancer safety data remain limited.
  • No validated lower cutoff for testosterone in women exists, per Wierman et al. (2014, JCEM), meaning a 'normal' result on a standard panel does not rule out clinically meaningful androgen insufficiency.
  • The FDA has not approved most compounded bioidentical hormone products. Compounded BHRT is not clinically equivalent to FDA-approved hormone therapies and can have inconsistent hormone concentrations between batches.
  • Emotional numbness and loss of relational connection, as Marcella describes, are also symptoms of depression, perimenopause-related sleep disruption, and anxiety. These should be evaluated before attributing the cause solely to hormones.
  • HSDD (hypoactive sexual desire disorder) is a recognized medical diagnosis. The ISSWSH 2019 position statement supports testosterone therapy as an option for postmenopausal women with HSDD under physician supervision.
  • If a provider dismisses low-libido symptoms with 'everything is normal,' current clinical guidance supports requesting free testosterone testing and a symptom-based evaluation, not just reference-range comparison.
  • Drinking alcohol to enable sexual desire, which Marcella mentions, is a recognized coping pattern for sexual dysfunction and is associated with its own downstream risks to relationship quality and health.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Marcella Hill · TikTok creator

5.5M views on this video

I felt numb. Didn't have any desire. I had no libido. I thought I was crazy. #marcellahill #wakeherup #hormonetherapy #hormoneimbalance #bhrt #womenshealth #nolibido #divorce

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Marcella Hill, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.